control mucosal challenge prevention aids multiprotein dna/mva vaccine
heterologous prime/boost regimens potential raising high levels immune responses report dna priming followed recombinant modified vaccinia ankara rmva booster controlled highly pathogenic immunodeficiency virus challenge rhesus macaque model dna rmva components vaccine expressed multiple immunodeficiency virus proteins two dna inoculations weeks single rmva booster weeks effectively controlled intrarectal challenge administered months booster findings provide hope relatively simple multiprotein dna/mva vaccine can help control acquired immune deficiency syndrome epidemic
